Actions
U.S. stocks fall as jobs data lifts Fed hike odds and Brent tops $99
Dow futures slipped after August payrolls beat expectations and Middle East strikes pushed Brent crude above $99, boosting September Fed rate-hike odds to about 60%.
European chip stocks rise on AI demand as Infineon gets Warburg buy
Infineon rose nearly 7% after Warburg upgraded it to Buy with a 84-euro target, while UBS lifted memory-chip revenue forecasts to $1.65 trillion by 2027.
Barclays keeps Swiss Re underweight, raises price target to 123 francs
Barclays lifted Swiss Re's price target from 116 to 123 Swiss francs but maintained an Underweight rating, saying first-half European insurance results masked weaker underlying trends.
Ohio Rep. David J. Taylor Buys, Sells Multiple Stocks in Recent Trades
The Ohio congressman purchased shares of American Electric Power, Broadcom and Fifth Third Bancorp while selling Amgen, Microsoft and Vertex Pharmaceuticals through two brokerage accounts.
California Rep. Gilbert Cisneros trades multiple tech and pharma stocks
The congressman's 150 Main Street Trust account, managed by Bank of America and Wells Fargo Advisors, bought shares in Accenture, AMD, Alkermes and others, while selling Alibaba and several other holdings, with transaction values ranging from $1,001 to over $250,000.
UBS maintains a neutral rating on Ashmore Group following an earnings miss
UBS has kept a neutral rating on Ashmore Group after the company posted an earnings miss.
Goldman Sachs Identifies Four European Telecom Stocks With Up to 62% Upside
The bank’s Digital Infrastructure team turned more bullish on Europe’s telecom sector, highlighting a second phase of free cash flow growth and balance sheet optionality for BT, Deutsche Telekom, Telefonica and Vodafone.
European stocks little changed ahead of ECB decision and US inflation data
European equities were little moved Monday as investors awaited the ECB decision and US inflation data; oil shares rose on Gulf tensions while the SMI fell on Novartis and Swiss Re.
US stocks retreat as oil crosses $100 and yields rise ahead of inflation data
U.S. equities fell as oil prices moved above $100 per barrel and bond yields increased before upcoming inflation figures.
Defensive ETFs and Certificates Offer Lower Volatility Amid Market Uncertainty
With world equity markets near record highs but facing rising US debt, upcoming elections and high oil prices, investors turn to diversified ETFs and tracker certificates that aim to limit downside risk.
CQS New City High Yield Fund issues 3.5m shares at 50.5p
CQS New City High Yield Fund Limited sold 3.5 million ordinary shares at 50.5 pence each, increasing total issued share capital to 723.25 million voting shares.
Galantas Gold Reports Warrant Exercise for 250,000 Shares at C$0.12
Galantas Gold Corporation said warrants over 250,000 ordinary shares were exercised at C$0.12 each on September 4, with new shares expected to trade on AIM around September 11.
DAX slips 0.15% to 26,006 as Brent holds above $97, ECB rate hike expected
Germany's blue‑chip index fell 0.15% to 26,006.53 points, staying just above the 26,000 threshold, while Brent crude traded above $97 per barrel and markets price an ECB rate rise to 2.5%.
SMI falls 0.8% as Novartis and Swiss Re lead losses
Switzerland's benchmark index closed at 14,279 after Novartis and Swiss Re weighed, while ABB, Kühne+Nagel and semiconductor suppliers offset some declines.
Why Fundamentally Oriented Investors Remain Essential for Equity Markets
Passive investing and momentum strategies are reshaping price discovery, making fundamentally driven managers increasingly important as counterweights when valuations detach from fundamentals.
Mirabaud sees Swiss equities as global niche leaders, not just defensive
Daniele Scilingo sees Swiss stocks as global niche leaders, warns AI valuations are stretched, and points to compounders, China adaptation, pharma innovation and UBS.
UBS maintains Neutral rating on Nestlé with CHF 80 price target
UBS kept its Neutral stance on Nestlé, citing a past suboptimal acquisition of the nutrition business that failed to meet expectations, and set a price target of 80 Swiss francs.
EuroStoxx 50 slides 0.8% as oil price rise fuels inflation fears
The Euro Stoxx 50 fell to 6,368.98, its lowest since early August, as higher oil prices and heightened Iran tensions revived inflation concerns and expectations of an ECB rate hike. Swiss and UK indices also moved modestly.
Deutsche Bank keeps Novartis at Buy on positive remibrutinib data
Deutsche Bank Research maintained a Buy rating on Novartis with a 140-franc price target after remibrutinib data in relapsing multiple sclerosis were described as clearly positive.
UBS Keeps Novartis at Neutral, Sets CHF 116 Target
UBS analyst Matthew Weston rates Novartis Neutral with a CHF 116 target, pricing remibrutinib MS success at 50% probability and $4.5 billion peak sales.
L'indice suisse SMI progresse grâce à l'ascension de Novartis malgré une prudence générale
L'indice des marchés suisses a clôturé légèrement plus fort mardi, soutenu par les gains de Novartis, bien que la plupart des valeurs de premier rang aient accusé des pertes, les prix à la consommation et les hausses des rendements obligataires pesant sur l'humeur des investisseurs.
RBC maintient son avis sous-performant sur Swiss Re avec un objectif de cours de 115 CHF
L'analyste Ben Cohen a maintenu la note sans modification après avoir actualisé ses modèles en fonction des résultats du deuxième trimestre, invoquant un surcapacitation dans le secteur de la réassurance et la prédominance de groupes plus vastes. L'opportunité de réexaminer les perspectives pour le segment de la réassurance de Swiss Re, qui reviendrait à 2027, reste un sujet d'intérêt majeur.
Medtronic, Swiss Life, Gerresheimer and Palo Alto Networks in focus amid AI power surge
A German market briefing highlights upcoming corporate events for four listed firms and warns that AI data centres now need gigawatt‑scale electricity, sparking interest in energy‑related equities.
UBS raises ASML price target to €2,350, sees more than half upside
UBS raised its ASML price target to €2,350 from €2,250 and kept a buy rating, citing pricing power, rising lithography intensity and a growing memory-chip business.